MARKET RECAP

Yesterday: Stocks ended flat Thursday after early gains faded, with utilities and financials leading while real estate lagged on rising bond yields. Upgraded Q3 GDP growth to 3.1% and lower-than-expected jobless claims highlighted economic resilience. Bond yields climbed, with the 10-year hitting 4.5% in anticipation of a slower rate-cut outlook.

On Our Radar: The next major economic reports focus on personal income and spending, providing additional clues about economic viability. Meanwhile, investors will have digested Carnival and Winnebago’s results, which should also offer an important gauge regarding consumer confidence.

TOP STORY

Trump Would 'Lead The Charge' To Scrap Debt Ceiling: 30-Year Treasury Bonds Slide To 2024 Lows, Stocks Cut Gains

Trump’s push to scrap the debt ceiling shook markets, driving 30-year Treasury yields to their highest levels of 2024. Bond ETFs tumbled, and stocks cut gains as fears of inflation and tighter Fed policy grew.

Here’s what’s fueling the market reaction — and what it means for investors.

SPONSORED CONTENT

Telomir Pharma Reports Its Compound Telomir-1 Shows The Ability To Turn Back The Clock On Aging 

Telomir Pharmaceuticals Inc. (NASDAQ: TELO) is one step closer to turning the clock back on aging with its novel compound Telomir-1 showing promise in a preclinical trial. 

In collaboration with Nagi Biosciences SA, Telomir said Telomir-1 proved its efficacy in a preclinical trial. The study demonstrated what Telomir said is significant age-reversal effects including an extended healthy lifespan, improved mobility and a measurable reversal of age-related decline.

“The results we’re seeing with Telomir-1 mark an important step forward in our journey to potentially reverse aging in humans,” said Erez Aminov, Chairman and CEO of Telomir Pharmaceuticals in a press release announcing the trial results. To learn more about this potentially revolutionary treatment click here. 

This is a paid ad. Please see 17b disclosure here for more information.

FIVE ZINGERS

Walking Off: With Christmas mere days away, thousands of Amazon warehouse workers walked off the job in a bid for better contract negotiations. Read the latest on where these discussions stand.

Mixed Bag: Tech giant Micron posted mixed Q1 earnings, beating its $1.76 EPS target by 3 cents but falling just short on revenue. Discover what analysts are saying amid the sharp pullback in MU stock.

Dip Diving: While gas pipeline operator DT Midstream has been a strong performer this year, DT stock has encountered volatility in recent sessions. Still, learn why Stifel analysts view the red ink as a buying opportunity.

Grinding Gears: Though EV sales have steadily increased over the years, aggressive incentives have also artificially boosted revenue. Here's what experts have to say about individual names in the sector.

Health Boost: Despite the controversies, U.S. healthcare spending grew by 7.5% to $4.9 trillion last year. Discover the main catalysts for this remarkable growth amid rising economic challenges.

ONE FOR THE ROAD

ETF Market Sets Records In 2024 As Inflows Reach $1.6 Trillion: 7 Funds Leading Charge

From record-breaking flows to innovative fund launches, Bank of America detailed $1.6 trillion in ETF inflows this year in a new note. The global ETF market has grown to a staggering $15.1 trillion in assets under management.

Additionally, ETF launches hit an all-time high of 1,485 in 2024, and institutional ownership continues to surge, cementing ETFs as the cornerstone of modern investment strategies.

Here's how the ETF ecosystem is evolving — and why it matters.

SPECIAL OFFER

30-Minute Trading Advantage, Free for 2 Weeks

Benzinga Pro alerts have led to major gains, like 270% on BLPH and 147% on CRBP. Access this market-shaping news before anyone else with Benzinga Pro’s free two-week trial. Click here to start now.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Ready to elevate your real estate game? This weekly newsletter provides actionable insights whether you are investing in REITs, owning property, or delving into the fast-growing world of fractional real estate. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets, and mind-blowing tech trends. Subscribe here.